AI Article Synopsis

  • The study investigates the role of Sec62 in cancer, showing its importance in tumor cell migration and stress tolerance.
  • Researchers performed Sec62/Ki67 dual staining on 100 cervical cytology specimens to identify high-grade dysplasia and cancer.
  • The results indicated that all high-grade cervical lesions (CIN3+) tested positive for the staining, demonstrating its effectiveness and reliability in detecting high-grade dysplastic lesions and assessing cancer risk.

Article Abstract

Purpose: In the previous studies, we demonstrated that Sec62 is essential for tumor cell migration, epithelial-to-mesenchymal transition, and intracellular stress tolerance. An increase in Sec62 expression correlated with an increase in cervical dysplasia severity in liquid-based cytology specimens. Ki67 is an established proliferation marker. Thus, in this study, we examined a method of Sec62/Ki67 dual staining for the detection of high-grade dysplasia and cancer in cervical liquid-based cytology specimens.

Methods: Sec62/Ki67 dual staining was performed on 100 cervical liquid-based cytology specimens. The staining results were correlated with cytological, immunocytological (p16/Ki67), colposcopic, and histological findings.

Results: All 56 (n = 56, 100%) cases of cervical intraepithelial neoplasia grade 3 and cervical cancer (CIN3+ lesions) were positive for Sec62/Ki67 staining, while low-grade lesions and normal cells were negative. Sec62/Ki67 staining was highly sensitive and specific for the detection of CIN2+ and CIN3+ lesions (94.37%; 100% and 100%; 84.09%, respectively).

Conclusions: Sec62/Ki67 dual-staining immunocytochemistry is a promising cytological tool for interpreting high-grade squamous lesions in cytological specimens and for assessing the risk of progression to cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-018-4981-4DOI Listing

Publication Analysis

Top Keywords

sec62/ki67 dual
12
dual staining
12
cytology specimens
12
liquid-based cytology
12
high-grade dysplasia
8
cervical liquid-based
8
cin3+ lesions
8
sec62/ki67 staining
8
sec62/ki67
6
staining
6

Similar Publications

Background: Head and neck squamous cell carcinomas (HNSCC) are frequently diagnosed in advanced stages, which limits therapeutic options and results in persistently poor patient outcomes. The aim of this study was to use liquid-based swab cytology (LBC) in combination with dual immunocytochemical detection of migration and proliferation markers Sec62 and Ki67 in order to allow non-invasive early detection of HNSCC as well as to analyse the diagnostic validity of this method for predicting the malignancy of suspicious oral lesions.

Methods: 104 HNSCC patients and 28 control patients, including healthy patients (n = 17), papilloma (n = 1) and leukoplakia patients (n = 10), were included in this study.

View Article and Find Full Text PDF

Purpose: The aim of this study was to analyze the diagnostic performance of a newly established immunocytochemical dual-staining protocol for the simultaneous expression of SEC62 and Ki67 in vulvar liquid-based cytology specimens for the identification of vulvar intraepithelial neoplasia (VIN) and vulvar cancer. In addition, we investigated the p16/Ki67 dual stain, which has already been established in cervical cytology.

Materials And Methods: For this pilot study, residual material from liquid-based cytology was collected retrospectively from 45 women.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of Sec62 in cancer, showing its importance in tumor cell migration and stress tolerance.
  • Researchers performed Sec62/Ki67 dual staining on 100 cervical cytology specimens to identify high-grade dysplasia and cancer.
  • The results indicated that all high-grade cervical lesions (CIN3+) tested positive for the staining, demonstrating its effectiveness and reliability in detecting high-grade dysplastic lesions and assessing cancer risk.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!